Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab
- 170 Downloads
We report a rare association of choroidal neovascularization (CNV) with retinitis pigmentosa and note its resolution by intravitreal injection of the anti-vascular endothelial growth factor (VEGF), bevacizumab. A classic choroidal neovascular membrane was seen in the right eye (RE) of a patient with sector retinitis pigmentosa. Bevacizumab 1.25 mg in 0.05 ml was injected intravitreally. The choroidal neovascular membrane was seen to regress following this single intravitreal bevacizumab injection with formation of a scar. CNV has very rarely been seen in association with retinitis pigmentosa. Anti-VEGF drugs have been shown to have a beneficial role in CNV with other causes; in this case their effectiveness in CNV associated with retinal dystrophies, for example retinitis pigmentosa, has been demonstrated.
KeywordsAnti-VEGF Bevacizumab Choroidal neovascular membrane Retinitis pigmentosa
- 1.Bressler NM, Bressler SB, Fine SL (2005) Neovascular (exudative) age related macular degeneration. In: Ryan SJ (ed) Retina, 4th edn. Elsevier Mosby, St. Louis, pp 1075–1111Google Scholar
- 4.Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol 117:1329–1345Google Scholar
- 6.Bergink GJ, Deutman AF, Van Daal WAJ (1992) Radiation therapy for subfoveal choroidal neovascular membranes in age-related macular degeneration: a pilot study. Int Ophthalmol 16:16Google Scholar